Nisa Investment Advisors
MRTX

Nisa Investment Advisors’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Nisa Investment Advisors’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-19,200
Closed -$1.34M – 2775
2022
Q3 		$1.34M Buy
19,200
+7,709
+67% +$570K 0.01% 737
2022
Q2 		$771K Buy
11,491
+8,900
+343% +$566K 0.01% 908
2022
Q1 		$213K Buy
2,591
+784
+43% +$80.2K ﹤0.01% 1352
2021
Q4 		$216K Sell
1,807
-210
-10% -$32.6K ﹤0.01% 1246
2021
Q3 		$357 Buy
2,017
+45
+2% +$7.24K ﹤0.01% 1224
2021
Q2 		$319 Sell
1,972
-1,350
-41% -$217K ﹤0.01% 1261
2021
Q1 		$569 Hold
3,322
– – ﹤0.01% 1132
2020
Q4 		$730K Buy
3,322
+2,122
+177% +$459K ﹤0.01% 1046
2020
Q3 		$199K Buy
1,200
+900
+300% +$123K ﹤0.01% 1312
2020
Q2 		$34K Buy
300
+80
+36% +$7.76K ﹤0.01% 1662
2020
Q1 		$17K Sell
220
-50
-19% -$4.48K ﹤0.01% 1749
2019
Q4 		$35K Buy
270
+120
+80% +$11.6K ﹤0.01% 1593
2019
Q3 		$12K Hold
150
– – ﹤0.01% 1752
2019
Q2 		$15K Hold
150
– – ﹤0.01% 1662
2019
Q1 		$11K Buy
+150
New +$10.2K ﹤0.01% 1731

Other funds holding MRTX

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Nisa Investment Advisors's MRTX Position: Q4 2022 in Review

Nisa Investment Advisors sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q4 2022, closing a stake of 19,200 shares — an estimated $1.34M sold.

Nisa Investment Advisors first reported a position in MRTX in Q1 2019 and held it in 15 quarters. The position peaked at $1.34M in Q3 2022. 233 funds tracked by Wall St. Rank hold MRTX as of Q4 2022.

  • Nisa Investment Advisors reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Nisa Investment Advisors sold 19,200 Mirati Therapeutics, Inc. Common Stock shares in Q4 2022, an estimated $1.34M.
  • Nisa Investment Advisors first reported a position in Mirati Therapeutics, Inc. Common Stock in Q1 2019 and held it in 15 quarters.
  • Nisa Investment Advisors's Mirati Therapeutics, Inc. Common Stock position peaked at $1.34M in Q3 2022.
  • 233 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q4 2022.

Based on Nisa Investment Advisors's 13F filing for Q4 2022, filed 2 Feb 2023.